Member Info for Hurst10

07.00 am NY and size buyer back in town.

He got a good prize

Worth remembering some of the MM's do not know enough about AVCT, they are " just " following orders. So any price sensitive news item company or sector, being released, will in some cases have a delay price reaction by them, while our usual MM's fully briefed by their analyst will respond and take advantage of late market reaction and a couple of minutes is all it takes to pick up size and use delayed reporting.

The real price right now at midday is 84-6, while waiting for any news at midday by our US CEO.

Try and pick up size below 80 right now and you will see what I mean.

Most of the prints are buys anyway.

Good luck.

With a million traded an hour and our buyer paying 83/4/5/6 this morning and then picking up more quietly in split sizes at 76/7/8/9, his average price will be very interesting , once we are back testing 88-90 in size, could be an eventful afternoon indeed, RNS or not, with our usual MM leading the rush on the bid to buy more and only one left on the offer. Any follow through buying from the crowd in NY , having listened to our US management , could easily push the stock back to new intra day highs.

Market trying to shake the tree and flush out some panic selling and take that stock and offer it back to the market at 85 shortly

MM and the market stepping up the pace, back at 1mill traded an hour, expect size order lifting offer and then follow through bids lifting it straight through 90.

Remember company could easily issue RNS US hours as before.

Size buyer moving back in again, usual MM on the bid!

Offer being lifted straight through 85, follow through buying and we will easily have 88-90 before US.

PS Novartis upgraded this morning on the back of their continued focus on oncology, precision medicine ,

You still have not answered our question:

What price did you pay and what price would you sell at?

I seem to remember when we were all buying all the way down and then all the way up ( 100% up recently ), You were very keen to point out how wrong we were, hmmm !

However you do make us laugh, keep up the good work!

When one reads your " comments ", it always remind me of another clown that used to work on the floor and when he spoke,we always reminded ourselves of the following " better to remain silent and be thought a fool, that to speak and remove all doubt". Keep up the good work. By the way you still have not told us of your buy price and target price???

You will now see the right MM moving in on the bid and the offer they will run for cover, size buyer will soon pay 80, as there is no on the offer at current level. Look at the crosses going through.

Amazing they let you have a phone at the clinic.

Size investor will chase the affimer and ignore the antibody

Lilly out shopping again in the Pharma sector!

Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057.

More funds entering ADC market,

UK biotech Myricx Bio has tapped into the red-hot interest among investors for companies working on antibody-drug conjugates (ADCs) for cancer, raising £90 million ($115 million) in a first-round co-led by Novo Nordisk parent Novo Holdings.

This transaction makes AVCT's precision ADC even more interesting,

Nasdaq IPO ( New York )

Dual listing

Jefferies and Cowen were working with Pieris and therefore would have close contact with our latest appointment

Q4 IPO !

Look at the US quoted companies she has worked with!

US IPO getting closer, post DCX exit and AVA news!

Just remind us all what is your target price?

Your obsession with trading calls and read them quite wrong is very sad, however I hope one day you will be a happy shareholder, who knows how to average a buying order, wish you good luck.

By the way did you all spot the post market print 75/ at 72 and 104/ at 67.80

That was a co-ordinated shake!

Classic!

7 1/2 mil in 7 1/2 hours of trading!

NY is stepping up the pace